This post was originally published on this site Obesity has a greater impact on the risk for diabetes among twins than on the risk for heart disease or death, according to a new study,”Risks of Myocardial Infarction, Death, and Diabetes in Identical Twin Pairs With Different Body Mass Indexes,“ developed by researchers from Umeå University, Sweden, and…
This post was originally published on this site A team of researchers led by Ioannis Papassotiriou, PhD, of Aghia Sophia Children’s Hospital in Athens, Greece has successfully tested a method for early diagnosis and treatment of pediatric diabetic nephropathy (kidney disease). The innovative method was presented during the 68th AACC Annual Scientific Meeting & Clinical Lab Expo.…
This post was originally published on this site Ascensia Diabetes Care announced the commercial launch and U.S. Food and Drug Administration (FDA) approval of its new blood glucose monitoring system Contour Next Link 2.4 for diabetes treatment management. “We are delighted that the MiniMed 630G system with the Contour Next Link 2.4 meter will now be available to people with…
This post was originally published on this site Emperra GmbH of Potsdam, Germany, is expanding its Esysta diabetes management product systems with what it says is the first Bluetooth insulin pen. The Esysta BT smart insulin pen logs injected insulin doses directly to the user’s digital blood glucose via the Bluetooth wireless interface, as well as being connected…
This post was originally published on this site The US Food and Drug Administration (FDA) has granted the fourth Orphan Drug Designation to Araim Pharmaceuticals’ ARA 290, an innate repair receptor (IRR) activator for increased survival and improved function of pancreatic islets after transplant in patients with Type 1 diabetes (T1B). “Obtaining this Orphan Drug Designation for ARA 290 is another…
This post was originally published on this site Insulin released by pancreatic beta (β) cells regulates blood glucose levels. If the system fails, it may cause hyperglycemia inducing Type 2 diabetes. But recent research indicates that a specific subset of β cells work like pacemakers and orchestrate insulin release by the pancreas, according to U. K. researchers in…
This post was originally published on this site Higher body mass index (BMI) does not increase the risk of heart attacks or death, but does increase the risk of developing diabetes, according to a study of 4,046 pairs of identical twins in Sweden. The study, “Risks of Myocardial Infarction, Death, and Diabetes in Identical Twin Pairs…
This post was originally published on this site The American Heart Association (AHA), with help from heart attack survivor Julie Kubala, of Superior, Wis., is launching a new educational campaign to reduce the number of repeat and recurrent heart attacks. Heart attack survivor Julie KubalaPhoto Credit: PRNewsFoto/American Heart Association Kubala, 48, was struck by heart attack just after…
This post was originally published on this site SciFluor Life Sciences announced that an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) is now in effect for SF0166 Topical Ophthalmic Solution, enabling the company to begin clinical trials in patients with wet age-related macular degeneration (AMD) and diabetic macular edema (DME). Allied Minds’…
This post was originally published on this site The U.S. Food and Drug Administration (FDA) approved Adlyxin (lixisenatide) as a new treatment for type 2 diabetes this week. The treatment consists of a daily injection that, combined with diet and exercise, can control blood sugar levels in adults with this common type of diabetes. Adlyxin is a…
